对于中度至重度的丹尼芬斯塔特:第二阶段,随机,双盲,安慰剂对照试验
Qinyi Chen1, Rixin Chen2, Liming Wu3
1Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
概括
丹尼芬斯塔特是一种新型脂肪酸合成酶抑制剂,在第二阶段试验中有效减少了病变. 50毫克的剂量对中度至重度的普通有希望,需要进一步调查.
科学领域:
- 皮肤病学和皮肤科学
- 药理学和治疗学 药理学和治疗学
- 炎症性皮肤疾病 炎症性皮肤疾病
背景情况:
- 是一种普遍的慢性炎症性皮肤疾病,具有显著的未满足的治疗需求.
- 目前对中度至重度的治疗方法往往具有局限性或副作用.
研究的目的:
- 评估denifanstat的安全性,耐受性和有效性,这是一种第一类脂肪酸合成酶抑制剂.
- 评估denifanstat在治疗中度至重度的潜力.
主要方法:
- 一个多中心,随机,双盲,安慰剂控制,剂量升级的第二阶段试验 (NCT05104125).
- 在12周内,每天晚餐后,每天服用一次denifanstat (25mg,50mg,75mg) 或安慰剂.
- 包括患有中度至重度的患者.
主要成果:
- 德尼芬沙特一般耐受良好,大多数治疗出现的不良事件 (TEAE) 轻度至中度 (例如,干眼,干皮).
- 在第12周,与安慰剂相比,使用denifanstat观察到病变总数显著减少 (p <0.05).
- 50毫克的denifanstat剂量显示了病变计数的显著减少,尽管研究人员的全球评估 (IGA) 降级在各组中没有达到统计学意义.
结论:
- 德尼芬斯塔特,特别是每天50毫克服用12周,耐受性很好,并显示出可能减少中度至重度的病变.
- 需要进行更大规模和更长期的研究来证实denifanstat的疗效和安全性.
关键词:
这是一种FASN抑制剂.一般性 (acne vulgaris) 是一种临床研究研究临床研究拒绝了他们的国家.有效性 有效性 有效性.随机的,随机的,随机的,随机的,随机的在安全方面,安全是安全的.更多相关视频
03:47Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
1.5K
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.1K
相关概念视频
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K